Abboud HA, Zelkó R, Kazsoki A (2025) A systematic review of liposomal nanofibrous scaffolds as a drug delivery system: a decade of progress in controlled release and therapeutic efficacy. Drug Deliv 32(1):2445259

Article  PubMed  Google Scholar 

Agarwal N, Jha AK (2025) DNA hypermethylation of tumor suppressor genes among oral squamous cell carcinoma patients: a prominent diagnostic biomarker. Mol Biol Rep 52(1):1–13

Article  Google Scholar 

Alduais Y, Zhang H, Fan F, Chen J, Chen B (2023) Non-small cell lung cancer [NSCLC]: a review of risk factors, diagnosis, and treatment. Medicine 102(8):e32899

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aria H, Rezaei M (2023) Immunogenic cell death inducer peptides: a new approach for cancer therapy, current status and future perspectives. Biomed Pharmacother 161:114503

Article  CAS  PubMed  Google Scholar 

Ashtiani HR, Bishe P, Lashgari NA, Nilforoushzadeh MA, Zare S (2016) Liposomes in cosmetics. J Skin Stem Cell 3(3):e65815

Google Scholar 

Basse C, Carton M, Milder M, Geiss R, Du Rusquec P, Daniel C et al (2024) Real-world survival impact of new treatment strategies for lung cancer: a 2000–2020 French cohort. Cancers 16(15):2768

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhatia S, Bhatia S. Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. Natural polymer drug delivery systems: nanoparticles, plants, and algae. 2016. p. 33–93.

Çağdaş M, Sezer AD, Bucak S (2014) Liposomes as potential drug carrier systems for drug delivery. Appl Nanotechnol Drug Deliv 25(1):1–50

Google Scholar 

Çevik UA, Işik A, Karakaya A (2025) ADMET and physicochemical assessments in drug design. Comput Methods Rational Drug Design 20:123–151

Article  Google Scholar 

Chang DK, Lin CT, Wu CH, Wu HC (2009) A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer. PLoS ONE 4(1):e4171

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Zhong X, Wu H, Liu Z, Nie X, Zhou L et al (2023) Synthesis of peptides from glycine on anatases with different crystal facets. Crystals 13(7):1113

Article  CAS  Google Scholar 

Chi YH, Hsiao JK, Lin MH, Chang C, Lan CH, Wu HC (2017) Lung cancer-targeting peptides with multi-subtype indication for combinational drug delivery and molecular imaging. Theranostics 7(6):1612

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Aniello A, Del Bene A, Mottola S, Mazzarella V, Cutolo R, Campagna E et al (2024) The bright side of chemistry: exploring synthetic peptide-based anticancer vaccines. J Pept Sci. https://doi.org/10.1002/psc.3596

Article  PubMed  Google Scholar 

Darla R, Gone P (2022) Role of peptidomimetics for new drug discovery. World J Adv Res Rev 16(2):271–291

Article  Google Scholar 

Gad A, Kydd J, Piel B, Rai P (2016) Targeting cancer using polymeric nanoparticle mediated combination chemotherapy. Int J Nanomed Nanosurg. 2(3):1–9. https://doi.org/10.16966/2470-3206.116

Article  Google Scholar 

Gao M, Zhang X, Yan H, Zhao Y, Yuan F, Sun D, Yang X, Ju Y, Wang L, Tao H, Tian L (2025) Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial. Therapeutic Adv Med Oncol 17:1–14

Google Scholar 

Garg P, Malhotra J, Kulkarni P, Horne D, Salgia R, Singhal SS (2024) Emerging therapeutic strategies to overcome drug resistance in cancer cells. Cancers 16(13):2478

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaurav I, Thakur A, Zhang K, Thakur S, Hu X, Xu Z et al (2024a) Peptide-conjugated vascular endothelial extracellular vesicles encapsulating vinorelbine for lung cancer targeted therapeutics. Nanomaterials 14(20):1669

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaurav I, Thakur A, Zhang K, Thakur S, Hu X, Xu Z, Kumar G, Jaganathan R, Iyaswamy A, Li M, Zhang G (2024b) Peptide-conjugated vascular endothelial extracellular vesicles encapsulating vinorelbine for lung cancer targeted therapeutics. Nanomaterials 14(20):1669

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez-Ling A, Vázquez OG, Bello ME, Robles R, Rascón-Gasca ML, Lara-Mejia L et al (2023) Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer. Palliat Support Care 21(4):608–615

Article  PubMed  Google Scholar 

Guo Y, Ashrafizadeh M, Tambuwala MM, Ren J, Orive G, Yu G (2024) P-glycoprotein [P-gp]-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators. Drug Discov Today. https://doi.org/10.1016/j.drudis.2024.104161

Article  PubMed  Google Scholar 

Hamidi M, Tabatabaei MS, Moslehi M, Barati M (2025) Introduction to novel drug delivery systems. Novel Drug Deliv Syst 13:1–34

Google Scholar 

Han R, Guo H, Shi J, Wang H, Zhao S, Jia Y et al (2023) Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer. Eur J Cancer 189:112919

Article  CAS  PubMed  Google Scholar 

Han SJ, Kim HH, Hyun D-g, Ji W, Choi C-M, Lee JC et al (2024) Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease. BMC Pulm Med 24(1):136

Article  PubMed  PubMed Central  Google Scholar 

Hartmann GG, Sage J (2024) Small cell lung cancer neuronal features and their implications for tumor progression, metastasis, and therapy. Mol Cancer Res 22(9):787–795

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778:357–375

Article  CAS  PubMed  Google Scholar 

Jalil AT, Abdulhadi MA, Al-Ameer LR, Taher WM, Abdulameer SJ, Abosaooda M et al (2024) Peptide-based therapeutics in cancer therapy. Mol Biotechnol 66(10):2679–2696

Article  CAS  PubMed  Google Scholar 

Jiang X, Gao L, Li Z, Shen Y, Lin ZH (2024) Development and challenges of cyclic peptides for immunomodulation. Curr Protein Pept Sci 25(5):353–375

Article  CAS  PubMed  Google Scholar 

Kirti A, Simnani FZ, Jena S, Lenka SS, Kalalpitiya C, Naser SS, Singh D, Choudhury A, Sahu RN, Yadav A, Sinha A (2024) Nanoparticle-mediated metronomic chemotherapy in cancer: a paradigm of precision and persistence. Cancer Lett 25:216990

Article  Google Scholar 

Kuang Z, Wang J, Liu K, Wu J, Ge Y, Zhu G et al (2024) Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.102804

Article  PubMed  PubMed Central  Google Scholar 

Kubota T (2023) An emerging role for anti-DNA antibodies in systemic lupus erythematosus. Int J Mol Sci 24(22):16499

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamers C (2022) Overcoming the shortcomings of peptide-based therapeutics. Future Drug Discov 4(2):FDD75

Article  CAS  Google Scholar 

Lamers C, Ricklin D, Lambris JD (2023) Complement-targeted therapeutics: an emerging field enabled by academic drug discovery. Am J Hematol 98:S82–9

Article  Google Scholar 

Lath A, Santal AR, Kaur N, Kumari P, Singh NP (2023) Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnol Genet Eng Rev 39(1):45–84

Article  CAS  PubMed  Google Scholar 

Lee VH, Traver RD, Taub ME (2024) Enzymatic barriers to peptide and protein drug delivery. Peptide and protein drug delivery. CRC Press, London, pp 303–358

Chapter  Google Scholar 

Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 20(9):624–639